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Abstract
Background: Neuroinflammation involves cytokine release, astrocyte reactivity and migration. Neuronal Thy-1
promotes DITNC1 astrocyte migration by engaging αVβ3 Integrin and Syndecan-4. Primary astrocytes express low
levels of these receptors and are unresponsive to Thy-1; thus, inflammation and astrocyte reactivity might be
necessary for Thy-1-induced responses.
Methods: Wild-type rat astrocytes (TNF-activated) or from human SOD1G93A transgenic mice (a neurodegenerative
disease model) were used to evaluate cell migration, Thy-1 receptor levels, signaling molecules, and reactivity markers.
Results: Thy-1 induced astrocyte migration only after TNF priming. Increased expression of αVβ3 Integrin, Syndecan-4,
P2X7R, Pannexin-1, Connexin-43, GFAP, and iNOS were observed in TNF-treated astrocytes. Silencing of β3 Integrin
prior to TNF treatment prevented Thy-1-induced migration, while β3 Integrin over-expression was sufficient to induce
astrocyte reactivity and allow Thy-1-induced migration. Finally, hSOD1G93A astrocytes behave as TNF-treated astrocytes
since they were reactive and responsive to Thy-1.
Conclusions: Therefore, inflammation induces expression of αVβ3 Integrin and other proteins, astrocyte reactivity,
and Thy-1 responsiveness. Importantly, ectopic control of β3 Integrin levels modulates these responses regardless
of inflammation.
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Background
Astrocytes are the main type of glial cell in the central
nervous system (CNS). Their functions range from nur-
sing neurons to forming the blood-brain barrier. Under
pro-inflammatory conditions induced by injury or neu-
rodegenerative disorders, such as Alzheimer’s disease
and amyotrophic lateral sclerosis (ALS), astrocytes be-
come reactive and take on a more stellate shape, while
increasing in number and size. At the same time, the ex-
pression of several proteins is enhanced, including that
of glial fibrillary acidic protein (GFAP) and inducible ni-
tric oxide synthase (iNOS) [1–5]. This reactive process is
referred to as astrogliosis [6–9]. Astrogliosis has been
recognized as an inhibitory cue for axon regeneration.
Nevertheless, it may have initial benefits for the injured
area, since astrocytes restrict any damage to a small area,
repair the blood brain barrier, and eliminate toxic factors
from the surrounding area [8–10]. During astrogliosis,
several molecules are released into the extracellular
space, including ATP, adenosine, and a number of cyto-
kines [8, 9]. One of the most important cytokines re-
leased to the injured area is tumor necrosis factor (TNF)
[9, 11], which acts as an alert signal that induces reactiv-
ity of the neighboring astrocytes [12, 13].
Reactive astrocytes are a heterogeneous population of
cells, and recent in vivo studies indicate that some astro-
cytes proliferate, while for another subset of labeled
astrocytes hypertrophy and polarization, but not overt
migration towards the site of injury are detected [14–16].
However, several previously reported studies indicate that
reactive astrocytes migrate to the damaged zone and form
the glial scar, repairing the wounded area [6, 10, 17]. The
protein osteopontin is among the various stimuli that
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induce cell migration; this requires interaction with
αVβ3 Integrin [18, 19]. Importantly, reactive astrocytes
have been shown to express increased levels of αVβ3
Integrin, the P2X7 receptor (P2X7R), and the hemi-
channels Connexin-43 and Pannexin-1 [4, 18, 20]. All
these molecules are reportedly involved in astrocyte
migration [21, 22].
The neuronal surface glycoprotein Thy-1 binds to
astrocytes and thereby promotes adhesion and migra-
tion, processes that our group has studied in depth.
Thy-1-induced adhesion and migration require inter-
action with the αVβ3 Integrin and Syndecan-4 receptors.
These interactions trigger the recruitment of focal adhe-
sion (FA) proteins and activate a signaling module,
which in turn leads to the activation of the small
GTPase RhoA and its effector ROCK and results in
changes in the astrocyte actin cytoskeleton [23–28]. The
signaling cascade also includes the opening of the hemi-
channels Connexin-43 and Pannexin-1 and the release
of ATP to the extracellular milieu, where it activates
P2X7R, allowing calcium entry [21, 22]. After a more
prolonged stimulation, Thy-1 induces the activation of
FAK, PI3-kinase, and the GTPase Rac1, thus leading to
astrocyte migration [26].
We have previously studied the Thy-1-induced signa-
ling cascade using the DITNC1 astrocyte cell line. Con-
sidering that, in primary astrocytes, many of the
molecules forming part of the Thy-1-induced signaling
pathway are only present in low amounts [29, 30], we
hypothesized that primary astrocytes would be refractory
to Thy-1 stimulus. Additionally, many signaling proteins,
including the Thy-1 receptors, are upregulated under
pro-inflammatory conditions [3, 4, 18, 20, 30]. We there-
fore decided to directly study the effect of a pro-
inflammatory environment on the response of primary
astrocytes to Thy-1, and on the Thy-1-induced signaling
cascade in these cells. This was achieved in two ways.
Firstly, primary astrocytes were treated with the pro-
inflammatory signaling factor TNF prior to Thy-1 appli-
cation, comparing the results to those obtained from
controls that had not been exposed to TNF. Secondly,
astrocytes were used derived from an ALS model, a neu-
rodegenerative disorder marked by neuroinflammation
and the presence of reactive astrocytes [31].
ALS is a late-onset disease, which generally appears
after 50 years of age. It is characterized by motor
neuron dysfunction and degeneration and leads to
death from respiratory failure [32–34]. Astrocytes from
ALS patient samples are activated [35] and show in-
creased levels of Connexin-43 and GFAP [3, 36]. In
murine ALS models, astrocytes are activated within a
time frame before the onset of disease [31, 37]. Add-
itionally, these reactive astrocytes are now recognized
to assist ALS motor neuronal death by secreting
inflammatory factors [33, 36, 38–42]. To study the ef-
fect of Thy-1 signaling on astrocytes developing under
the ALS neuroinflammatory conditions, the transgenic
mouse carrying the human G93A mutated super oxide
dismutase 1 (hSOD1G93A) was employed, the most
widely used ALS model [1, 3, 33, 36, 39, 41–43].
As discussed above, Thy-1-mediated astrocyte adhe-
sion and migration relies on the αVβ3 Integrin receptor.
Because β3 Integrin is upregulated in the presence of
TNF in various cell types [18, 44, 45], it could be hy-
pothesized that the effect of TNF on astrocyte reactivity
is related to β3 Integrin expression. To further explore
the role of this receptor molecule, Thy-1 signaling in
primary astrocytes was therefore investigated, in which
β3 Integrin expression had been either silenced or up-
regulated, both in the presence and absence of TNF.
Here, we show that primary astrocytes only
responded to Thy-1 in a pro-inflammatory environment
(+TNF), where proteins participating in the Thy-1 re-
sponse were upregulated. In addition, neonatal primary
astrocytes derived from a mouse model of ALS
(hSOD1G93A) were found to express higher levels of re-
activity markers and β3 Integrin, Syndecan-4, Connexin-
43, and Pannexin-1 than those derived from wild-type
non-transgenic littermates. The hSOD1G93A-derived as-
trocytes responded to Thy-1 without the need of cytokine
addition. Importantly, in investigating the role of β3 Integ-
rin in Thy-1-induced FA and astrocyte migration, over-
expression of β3 Integrin was found to be sufficient to
render primary astrocytes reactive and consequently re-
sponsive to Thy-1 stimulation in the absence of TNF.
Conversely, silencing of β3 Integrin precluded the effect of
Thy-1 on TNF-treated astrocytes. These results favor a
working model in which inflammation enhances β3 Integ-
rin expression, rendering astrocytes responsive to Thy-1
and thereby promoting their adhesion and migration, as
required during the repair of the injured brain. Control-
ling β3 Integrin levels modulated astrocyte reactivity.
Methods
Animals
The care and use of rodents is detailed in protocols
approved by the bioethical Committees of the Universi-
dad de Chile and Universidad Andres Bello. Wistar neo-
natal rats (P1-P2) were obtained from the Universidad
de Chile animal facility. Transgenic mice hemizygous for
human SOD1G93A (hSOD1G93A) or non-transgenic mice
(used as a control) were obtained from the Jackson La-
boratory (Bar Harbor, USA). Transgenes were detected
by PCR [39].
Primary cultures
Astrocytes were obtained from 1- to 2-day-old wild-type
rats or non-transgenic and hSOD1G93A mice. Briefly,
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wild-type rats were sacrificed by decapitation. Brains
were extracted and placed in ice-cold PBS under a
microscope. Cortices were separated from brain and
meninges and kept in fresh ice-cold PBS. To isolate the
cells, cortices were treated with trypsin and mechanically
disrupted. The resulting cell suspensions were passed
through a 70-μm cell strainer, washed with DMEMF-12
(Gibco, Life Technologies, Grand Island, NY) supple-
mented with 10% FBS, and centrifuged at 1000 rpm. Fol-
lowing this, cells were counted and seeded at a density
of 1.5 million cells per T-25 cell flask. The cell medium
was changed every 48 h. Once confluent, neurons and
other cell types were released to the supernatant by
shaking in an orbital shaker at 180 rpm overnight. To
induce a pro-inflammatory environment, rat primary as-
trocytes were stimulated with 10 ng/ml of TNF for 48 h.
IL-1β, IL-6, or IFN-γ (R&D systems) were also used
(kindly donated by Dr. Rommy von Bernhardi, P. Uni-
versidad Católica de Chile). Murine astrocyte cultures
were prepared from the ventral spinal cord of P1-P2
hSOD1G93A transgenic mice, or from non-transgenic lit-
termates as previously described [39, 41, 42]. Cultures
were maintained in DMEM (Gibco, Life Technologies,
Grand Island, NY) containing 10% FBS and 1% penicillin-
streptomycin at 37 °C, 5% CO2. Cultures reached con-
fluence after 2–3 weeks and contained > 95% GFAP+
astrocytes. Residual microglia were removed from both
mouse and rat astrocytes by shaking cultures in an orbital
shaker overnight (200 rpm).
Thy-1-Fc and Trail-R2-Fc preparation
Thy-1-Fc (wild-type and mutants) and Trail-R2-Fc fu-
sion proteins were obtained as previously described
[21, 26]. Prior to their use, Thy-1-Fc and Trail-R2-Fc
were incubated with Protein A in a 10:1 ratio wile ro-
tating gently on a shaker for 1 h at 4 °C. Trail-R2-Fc is
a fusion protein of the receptor for the soluble
apoptosis-inducing ligand Trail-R2, which is used as a
control for possible non-specific effects caused by the
Fc portion of the Thy-1 fusion protein [21]. Prior to
each experiment involving Thy-1-Fc or Trail-R2-Fc
treatment, astrocytes were serum-starved for at least
30 min in DMEM without serum.
Focal adhesion assay
Primary astrocytes were seeded on 12-mm coverslips
and left to adhere for 24 h. Cells were then pre-treated
with 10 ng/ml of TNF for 48 h to induce reactivity.
Afterwards, astrocytes were rinsed with DMEM and left
in serum-free medium for 30 min. This medium was
then removed, and cells were incubated for 15 min with
4 μg of either Thy-1-Fc or Trail-R2-Fc coupled to Pro-
tein A in serum-free medium. FBS (3% for 5 min) was
used as a positive control. Astrocytes were then washed
and fixed for 10 min with 4% paraformaldehyde, perme-
abilized with 0.1% Triton X-100 for 10 min, and blocked
in 2% bovine serum albumin (BSA)-PBS for 1 h. Cells
were then incubated with anti-vinculin antibody (1:200,
Sigma-Aldrich Co., Saint Louis, MO) for 1 h at 37 °C to
stain for focal adhesions. Rhodamine-conjugated Phal-
loidin (Sigma-Aldrich Co., Saint Louis, MO) and DAPI
(Sigma-Aldrich Co.) (0.025 μg/ml) were used to stain F-
actin and nuclei, respectively. Quantification of focal ad-
hesion area and number was performed as described
previously [21, 26].
Transfection of primary astrocytes
Astrocytes were transfected with pEGFP-β3 Integrin (full
length β3 Integrin subunit kindly donated by Dr. C.
Rüegg, University of Friboug, Switzerland [46]) or a pool
of three siRNAs against β3 Integrin (Ambion) using the
Amaxa Nucleofector system following the manufac-
turer’s instructions for the VPI-1006 transfection kit and
the program T-020 (Lonza, Cologne, Germany).
Wound-healing assay
Primary astrocytes were seeded in 24-well plates
(100,000 cells per well). After 48 h of incubation in
complete medium with or without TNF (10 ng/ml), two
parallel wounds were introduced with a micropipette tip.
Detached cells were washed away with serum-free
medium, and after 30 min of starvation, cells were stim-
ulated with 4 μg of Thy-1-Fc, Thy-1(RLE)-Fc, or Trail-
R2-Fc (negative control) in serum-free medium for 24 h.
All proteins were coupled to Protein A as indicated
above. Alternatively, primary astrocytes were transfected
with pEGFP-β3 Integrin or siRNA against β3 Integrin,
prior to wounding cell monolayers and stimulating as
above without TNF pre-treatment. Wound healing was
evaluated based on images of the cell-free area at 0 and
24 h, as previously described [21, 26].
Western blot
Protein extracts were prepared in a lysis buffer
(150 mM NaCl, 0.1% SDS, 0.25% sodium deoxycholate,
1% Triton-X100, in 50 mM Tris-HCl pH 7.4) sup-
plemented with protease and phosphatase inhibitor
cocktail (Biotool, Houston, TX). Extracts were electro-
phoretically separated on 10% SDS-PAGE gels and
transferred to nitrocellulose (Millipore, Billerica, USA).
The nitrocellulose was blocked with 5% w/v nonfat, dry
milk in PBS containing 0.1% Tween-20 and subse-
quently incubated with the following primary anti-
bodies: anti-β3 Integrin (1:2000, Millipore, Billerica,
USA), anti-Syndecan-4 (1:2000, Abbexa, Cambridge,
UK), anti-iNOS (Abbexa), anti-Connexin-43 (1:500;
Santa Cruz Biotechnologies Dallas, TX), anti-Pannexin-
1 (1:500; Santa Cruz Biotechnologies), anti-P2X7R
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(1:1000, Santa Cruz Biotechnologies), anti-GFAP
(1:2000, Sigma-Aldrich Co.), and anti-misfolded human
SOD1 (C4F6) (MediMabs, Quebec, Canada). The mem-
brane was then washed and incubated with horseradish
peroxidase-conjugated goat anti-rabbit IgG (1:5000;
Abbexa, Cambridge, UK) or donkey anti-goat IgG
(1:5000; Abbexa) for 1 h at room temperature. Bands
were visualized with a chemiluminescence kit (Pierce,
Thermo Scientific, Rockford, IL), according to the man-
ufacturer’s instructions. We performed Western blot
quantification by measuring band intensity in Photo-
shop 7 (Adobe) and normalizing to the corresponding
loading control. To determine fold increase, all values
were normalized to the average value obtained for con-
trol bands after any treatment.
Indirect immunofluorescence assay
Astrocytes were seeded on 12-mm coverslips and left to
adhere for 24 h. Cells were then washed and fixed as in-
dicated for the focal adhesion assay. Next, cells were
stained with anti-Connexin-43 (1:200), anti-Pannexin-1
(1:200), anti-Syndecan-4 (1:200) or anti-P2X7R (1:200)
antibodies followed by secondary antibodies (1:400) con-
jugated to IF488 or IF594 (Abbexa), and DAPI
(0.025 μg/ml). Samples were analyzed using a confocal
microscope C2+ (Nikon, Japan), with a 60×/1.40 object-
ive and using the NIS-Elements software.
Extracellular ATP measurements
Twelve thousand primary astrocytes were seeded in 48-
well plates. After 24 h, cells were incubated in serum-free
media containing 100 μM of the exonuclease inhibitor
ARL-67156 (Santa Cruz Biotechnologies) for 30 min at
37 °C. Following this, cells were stimulated with Thy-1-
Fc:Protein A for 15 min. Where indicated, cells were incu-
bated with a combination of Heptanol (Sigma-Aldrich
Co.) (500 μM) and Probenecid (Sigma-Aldrich Co.)
(1 mM). Next, culture medium was recovered and centri-
fuged for 5 min at 1000×g. The supernatants were incu-
bated in the dark with 50 μl CellTiter-Glo® reaction mix
(Promega, Madison, WI). Luminescence intensity was
determined in a Synergy2 multi-mode reader (Biotek In-
struments, Inc., Vermont), and the values were interpo-
lated using a calibration curve obtained from different
ATP concentrations (0.01, 0.1, 1, and 10 μM).
Measurement of intracellular calcium kinetics
Primary astrocytes were seeded on 25-mm coverslips
(400,000 cells) and left to adhere for 24 h. The cells were
then incubated with 5 μM Fluo-4-AM (Life Technolo-
gies, Grand Island, NY) in Ringer solution at 37 °C for
30 min, after which they were washed and left in the
same solution. Following this, astrocytes were treated
with the hemichannel blockers Heptanol (500 μM) and
Probenecid (1 mM) for 30 min. Alternatively, they were
treated with the P2X7R blocker BBG (American Bioana-
lytical, Natick, MA) (5 μM for 1 h). Images were ac-
quired at 2-s intervals with an XM10 camera (Olympus
Corp.). Thy-1-Fc or Trail-R2-Fc, both coupled to Protein
A, were added 120 s after initiating acquisition. Fluores-
cence intensity was quantified in 100 cells per condition
using ImageJ. The results were expressed as (F-F0)/F0,
where F is the change in fluorescence and F0 is the basal
fluorescence. To measure calcium in astrocytes trans-
fected with pEGFP-β3 Integrin, cells were loaded with
the red probe Cal-590 AM (AAT Bioquest) at 4 μM fol-
lowing the manufacturers’ protocol.
Statistical analyses
Results are shown as the means ± standard error of the
mean (s.e.m.) for n = 3 or more experiments. The results
were analyzed using Kruskall-Wallis test and Dunn’s
post-test. Statistical significance was set at p < 0.05.
Results
A pro-inflammatory stimulus endows primary astrocytes
with Thy-1 responsive properties
Thy-1 has been shown to induce of DITNC1 astrocyte
migration by engaging αVβ3 Integrin and Syndecan-4
[26] and triggering signaling pathways downstream of
these receptors [21]. Here, the effect of Thy-1 on wild-
type primary astrocytes was tested. To this end, rat as-
trocytes were isolated from neonatal brains. Primary cul-
tures were prepared for FA and migration assays and
starved for 30 min prior to the treatment with Thy-1-Fc,
serum (FBS, positive control), or Trail-R2-Fc (negative
control) [21, 26]. Cells forming FAs were monitored by
vinculin staining, whereas cell migration was evaluated
in a wound-healing assay. We found that, unlike FBS-
treated astrocytes, the stimulation with Thy-1-Fc did not
lead to FA formation and the cells were morphologically
similar to non-stimulated control cells (Fig. 1a).
Because only reactive astrocytes migrate after damage
to the CNS [2], primary astrocytes were thought to
require activation to respond to Thy-1 stimulation.
Thus, astrocytes were treated with TNF to emulate a
pro-inflammatory environment and tested for the astro-
cyte reactivity markers GFAP and iNOS. Levels of these
proteins were increased by TNF treatment (Additional file 1:
Figure S1A). Astrocyte morphology also changed (Additional
file 1: Figure S1B), indicating the presence of reactive
astrocytes in these TNF-treated cultures.
Importantly, TNF-treated astrocytes became respon-
sive to the addition of Thy-1-Fc, which induced forma-
tion of FAs and stress fibers (Fig. 1a). Our results show
that Thy-1 stimulated only those cells previously treated
with TNF (Fig. 1b) or other pro-inflammatory cytokines
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(Additional file 1: Figure S1C), while stimulation with
serum induced FA formation in cells with or without
TNF pre-treatment (Fig. 1a, b). The effect of Thy-1-Fc
on astrocyte migration was also tested for these astro-
cytes. As expected, primary astrocytes migrated upon
Thy-1 stimulation only when cells were previously
treated with TNF (Fig. 1c, d). As shown for FA, serum-
treated cells responded independently of TNF treatment
(Fig. 1c, d). These results show that primary astrocytes
assembled FA and migrated in response to FBS, but that
they were insensitive to Thy-1 unless previously acti-
vated with TNF or other pro-inflammatory cytokines.
TNF pre-treatment enables Thy-1 signaling in astrocytes
Thy-1 binding to αVβ3 Integrin in DITNC1 astrocytes
has been recently demonstrated to be followed by intra-
cellular signaling events that include opening of the he-
michannels Pannexin-1 and Connexin-43 and release of
ATP to the extracellular milieu [21]. The ATP activates
P2X7R, allowing Ca2+ entry and PKCα activation,
followed by Syndecan-4-triggered signaling pathways
[22]. The presence of these receptors as well as the acti-
vation of similar signaling pathways in wild-type rat pri-
mary astrocytes treated with TNF and stimulated by
Thy-1 was therefore explored.
We found that pretreatment with TNF increased the
levels of β3 Integrin, Syndecan-4, P2X7R, Connexin-43, and
Pannexin-1 (Fig. 2a). β3 Integrin levels were also enhanced
by other pro-inflammatory cytokines (Additional file 2:
Figure S2). Next, the subcellular localization of these
proteins was evaluated. Connexin-43 was located mainly
in vesicles near the nucleus in untreated primary astro-
cytes but was redistributed to the cell periphery upon
TNF treatment (Fig. 2b). Notably, this staining pattern
was also observed in isolated cells, indicative of hemi-
channel rather than gap junction configuration for
Connexin-43. Pannexin-1 was also redistributed; after
TNF treatment, it appeared at the tip of cellular protru-
sions (Fig. 2b). The intensity of Syndecan-4 and P2X7R
Fig. 1 TNF treatment is required for Thy-1-induced focal adhesion formation and migration in primary astrocytes. a Representative images of focal
adhesions (FA) in non-stimulated (NS) astrocytes or astrocytes exposed to serum (FBS) or Thy-1-Fc in the presence or absence of TNF. Trail-R2-Fc
is used as a negative control. Magnification bar = 50 μm. b Quantification of the number of cells showing FA in primary astrocytes treated with
TNF. Cells containing elongated FAs, which showed at least a 1.5-fold increase in the number of FAs compared to non-stimulated cells, were scored as cells
with FAs [25]. FAs were observed in primary astrocytes treated with Thy-1 after TNF treatment, or with FBS. c Representative images of wound-healing
assays in pseudocolor. Green cells: primary astrocyte cultures at 0 h. Red cells: primary astrocytes at 24 h after treatment. Magnification bar = 100 μm.
dWound-healing assay quantification in astrocytes treated with Trail-R2-Fc, Thy-1, or FBS for 24 h in the presence or absence of TNF. Thy-1 induces
migration only in cells previously treated with TNF, whereas serum closes the wounded area in both conditions. Values shown in all graphs are the
means ± s.e.m. from three independent experiments. *p < 0.05; ***p < 0.001
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fluorescent signals increased, but neither receptor
showed changes in localization (Fig. 2b).
Since hemichannel protein levels increased following
TNF treatment, and because ATP is released by
hemichannel opening upon Thy-1 stimulation [21, 22],
ATP release to the extracellular medium in cells treated
with TNF followed by Thy-1 stimulation was measured.
ATP was released only when cells were pre-treated with
Fig. 2 TNF pre-treatment enables Thy-1 signaling in primary astrocytes. a Representative western blot of β3 Integrin, Syndecan-4, P2X7R, Connexin-43,
and Pannexin-1 after 48 h of treatment with TNF. Values indicate fold increase. b Localization of Connexin-43, Pannexin-1, Syndecan-4, and P2X7R in
TNF-treated astrocytes and control cells (in green). Nuclei appear in blue. Magnification bar = 50 μm. c ATP measurements in the extracellular medium
of primary astrocytes treated with Trail-R2-Fc or Thy-1-Fc for 10 min. Cells were previously treated, or not, with TNF for 48 h and incubated with the
Connexin-blocking drug Heptanol (500 μM) and the Pannexin-blocking drug, Probenecid (1 mM). d Quantification of intracellular calcium levels in TNF-
treated astrocytes stimulated with Thy-1-Fc and pre-treated with Heptanol and Probenecid or the P2X7R inhibitor BBG (5 μM). Trail-R2-Fc was used as a
negative control. Values are 1.61 ± 0.27 for Thy-1+TNF, 1.08 ± 0.09 for Thy-1+TNF+BBG, 1.01 ± 0.02 for Thy-1+TNF+Pro-Hep, 1.06 ± 0.04 Trail-R2-Fc+TNF
and 1.04 ± 0.04 for Thy-1 without TNF. e Wound-healing assay in rat primary astrocytes. After treatment with BBG (5 μM), Apyrase (3 UI/mL), or vehicle
(PBS), cells were stimulated with Trail-R2-Fc, Thy-1-Fc for 24 h. Values shown are the means ± s.e.m. from three independent experiments. *p < 0.05
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TNF. The hemichannel blockers Probenecid and Hepta-
nol reduced ATP release to control levels (Fig. 2c). Be-
cause extracellular ATP activates the purinergic receptor
P2X7, intracellular calcium levels ([Ca2+]i) were mea-
sured following Thy-1 stimulation with and without
TNF treatment. Intracellular calcium concentrations
were increased by Thy-1 addition (to a maximum value
of 1.61 ± 0.27) only in astrocytes pre-treated with TNF
(Fig. 2d). In addition, blocking the hemichannels with a
mixture of Probenecid and Heptanol or inhibiting
P2X7R with Brilliant Blue G (BBG) abolished most of
the [Ca2+]i increase induced by Thy-1 stimulation, with
maximum values reaching 1.01 ± 0.02 and 1.08 ± 0.09,
respectively (Fig. 2d). Of note, TNF treatment per se
showed no effect on ATP release or [Ca2+]i as observed
in cells treated with TNF and Trail-R2-Fc compared to
those treated only with Trail-R2-Fc (Fig. 2c, d).
These results indicate that hemichannel opening, ATP
release, P2X7R activation, and Ca2+ uptake are import-
ant steps in the signaling pathway triggered by Thy-1 in
reactive primary astrocytes. In line with this, the ATP
hydrolyzing enzyme Apyrase and the P2X7R inhibitor
BBG both precluded Thy-1-induced migration of acti-
vated astrocytes (Fig. 2e). Therefore, and as previously
reported for DITNC1 astrocytes [21, 22], these results
demonstrate that ATP release and Ca2+ uptake via
P2X7R are fundamental to the Thy-1-induced migration
of astrocytes.
Over-expression of β3 Integrin is sufficient to allow Thy-1-
induced migration in non-activated astrocytes
Since β3 Integrin expression was enhanced after TNF
treatment in primary astrocytes (Fig. 2a), and because
αVβ3 Integrin is a receptor for Thy-1 [21–26, 28, 47–49],
the role of this Integrin in Thy-1-induced astrocyte mi-
gration was further explored. To this end, astrocytes
transfected with siRNA targeting β3 Integrin were
treated with TNF. β3 Integrin-silenced cells were found
to contain low levels of β3 Integrin (not shown). These
levels were kept low even after TNF treatment, in com-
parison to TNF-treated cells transfected with the control
siRNA (Fig. 3a). The β3 Integrin role in Thy-1-induced
migration was then evaluated in a wound-healing assay.
Thy-1-induced migration was diminished in β3 Integrin-
silenced cells compared with TNF-treated cells transfected
with the control siRNA (Fig. 3a). The negative control
Trail-R2-Fc had no effect on astrocyte migration (Fig. 3a).
Considering that TNF treatment induced the up-
regulation of many surface proteins, and that β3 Integrin
silencing was enough to prevent Thy-1-induced migra-
tion, the effect of the β3 Integrin over-expression in the
absence of TNF treatment was evaluated. Successful
transfection of astrocytes with a vector containing
pEGFP-β3 Integrin was corroborated by evaluating β3
Integrin levels with immunoblotting (Fig. 3b). Using a
wound-healing assay, the β3 Integrin over-expression
was observed to render astrocytes responsive to Thy-1,
which promoted wound closure even in the absence of
pro-inflammatory stimuli (Fig. 3b). Notably, β3 Integrin
over-expression led to increased levels for many other key
components of the Thy-1 response, including Syndecan-4,
P2X7R, Connexin-43, and Pannexin-1 (Fig. 3c). Together,
these results indicate that β3 Integrin over-expression is
sufficient to permit Thy-1-induced migration of primary
astrocytes, without the requirement for TNF treatment,
and that this effect might be due to a role for β3 Integrin
in controlling the expression of other key components of
the Thy-1 signaling pathway.
To confirm that the effect of Thy-1 on wild-type pri-
mary astrocytes is mediated through the interaction of
Thy-1 and αVβ3 Integrin, a mutant Thy-1 carrying an
amino acid substitution in the αVβ3 Integrin-binding do-
main was used to stimulate TNF-treated astrocytes. Im-
paired functionality of this mutated protein has been
previously reported [21, 26]. Our results show that, in
contrast to wild-type Thy-1, mutant Thy-1 did not in-
duce astrocyte migration (Fig. 3d) confirming the im-
portance of Thy-1/αVβ3 Integrin interaction in the
reported effects.
Having confirmed β3 Integrin as a crucial mediator of
Thy-1-triggered adhesion and migration, processes
shown here to be limited to reactive astrocytes, and con-
sidering its upregulation in the presence of TNF, we
were curious to explore whether the over-expression of
this integrin had any general effects on astrocyte reactiv-
ity. The levels of the known markers of astrocyte reactiv-
ity iNOS and GFAP in pEGFP-β3 Integrin transfected
astrocytes by western blotting were therefore evaluated.
Importantly, β3 Integrin over-expression, but not EGFP
used as a control, was found to increase the expression
of these molecules (Fig. 3e), suggesting that the sole en-
hanced expression of this integrin was sufficient for
these astrocytes to show properties of reactivity. More-
over, Thy-1 engagement of overexpressed β3 Integrin in
astrocytes increased intracellular [Ca2+] and ATP levels
(Additional file 3: Figures S3A and S3B). Taken together,
these observations indicate that β3 integrin represents a
key molecule in the Thy-1-induced signaling.
Importantly, these results uncover a critical role for β3
Integrin in primary astrocyte activation in a pro-
inflammatory environment, a striking and unexpected
function for this cell adhesion molecule in astrocytes.
Thy-1 responsiveness increases in astrocytes derived from
transgenic hSOD1G93A mice
Neuroinflammatory diseases, such as ALS, involve cyto-
kine release from various glial cells in the CNS [11].
Both in ALS patients and murine models of the disease,
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Fig. 3 β3 Integrin expression levels affect Thy-1-induced astrocyte migration. a β3 Integrin knock-down reduces Thy-1-induced astrocyte migration. β3
Integrin levels and wound-healing assay quantification in β3 Integrin knock-down, TNF-treated astrocytes stimulated with Trail-R2-Fc or Thy-1-Fc.
b Over-expression of β3 Integrin is sufficient to allow Thy-1-induced astrocyte migration. β3 Integrin levels and wound-healing assay quantification in
β3 Integrin over-expressing astrocytes stimulated with Trail-R2-Fc or Thy-1-Fc. c Western blot of proteins of the Thy-1-induced signaling pathway in
astrocytes over-expressing GFP-tagged β3 Integrin. d Wound-healing assay in TNF-treated astrocytes stimulated with Thy-1(RLE)-Fc, a Thy-1-Fc mutant
that lacks the β3 Integrin-binding domain. e Western blot of markers of reactivity in astrocytes over-expressing GFP-tagged β3 Integrin. β actin is used
as a loading control. Values shown in graphs are the means ± s.e.m. from three independent experiments. *p < 0.05; ***p < 0.001
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astrocytes become reactive in the spinal cord, lateral cor-
ticospinal tracts and in different brain regions before the
appearance of motor symptoms [31, 50, 51]. It is there-
fore of interest to study the Thy-1 responsiveness of as-
trocytes derived from a murine model of ALS. Here,
astrocytes from hSOD1G93A mice and from their non-
transgenic littermates were used [1, 3, 36, 41–43].
The activation state of these ALS astrocytes was first
assessed by measuring the levels of the reactivity
markers GFAP and iNOS by western blotting. The levels
of both proteins were found increased when compared to
astrocytes from non-transgenic animals (Additional file 4:
Figure S4). In addition, vinculin and F-actin staining of
non-transgenic and hSOD1G93A-derived astrocytes re-
vealed differences in their FAs and actin cytoskeleton. As-
trocytes from non-transgenic mice were round in shape
with low levels of FAs, while hSOD1G93A-derived astro-
cytes were polygonal with better-defined actin stress fibers
and fewer focal contacts (Fig. 4a, upper panels). Following
Thy-1 addition, astrocytes from non-transgenic mice did
not change, while hSOD1G93A-derived astrocytes showed
an increased number of FAs and robust stress fibers
(Fig. 4a, bottom panels). Next, migration was evaluated in
a wound-healing assay. Only hSOD1G93A-derived astro-
cytes were found to have migrated after Thy-1-Fc
stimulation (Fig. 4b). As expected, the addition of Thy-
1(RLE)-Fc, which lacks the β3 Integrin-binding domain,
had no effect on the migration of hSOD1G93A-derived as-
trocytes (Fig. 4b). These results confirm that hSOD1G93A-
derived astrocytes, like TNF-activated wild-type primary
astrocytes (see Fig. 1), respond to Thy-1 through αVβ3
Integrin interaction, thereby increasing cell adhesion and
migration.
Because increased levels of αVβ3 Integrin, Syndecan-4,
Connexin-43, Pannexin-1, and P2X7R had been detected
in TNF-treated rat wild-type primary astrocytes,
hSOD1G93A-derived astrocytes were tested for similar in-
creases in the levels of these proteins. Except for P2X7R,
all of these proteins were found to be upregulated in
these cells (Fig. 4c).
Together, these results confirm that hSOD1G93A-de-
rived astrocytes are reactive, show increased expression
of surface proteins involved in Thy-1-induced signaling,
and enhanced adhesion and migration after Thy-1-Fc
stimulation. It is intriguing that, despite their early post-
natal origin (P1-P2 stages), hSOD1G93A-derived astro-
cytes showed properties of reactive astrocytes after only
4 weeks in culture, suggesting that despite their early
origin, these astrocytes were already primed to become
reactive.
Discussion
Inflammatory cytokines are widely considered causative
in triggering astrocyte reactivity [52]. Here, we show
that wild-type primary astrocytes respond to Thy-1 by
adhering and migrating only under inflammatory con-
ditions (+TNF). We also show that in primary astro-
cytes, Thy-1 induces similar signaling pathways to
those reported for DITNC1 astrocytes, namely,
Fig. 4 Characterization of astrocytes derived from hSOD1G93A mice and from their non-transgenic littermates. a Representative immunofluorescence
images showing FA (red) and stress fibers (green) in non-transgenic and hSOD1G93A-derived astrocytes in the presence or absence of Thy-1-Fc
stimulation. Nuclei appear in red. Magnification bar = 50 μm. b Quantification of wound-healing assays on non-transgenic and hSOD1G93A-derived
astrocytes treated with Trail-R2-Fc, Thy-1-Fc, Thy-1(RLE)-Fc, or serum (FBS). c Western blot of β3 Integrin, Syndecan-4, Connexin-43, Pannexin-1, P2X7R,
and mutant hSOD1 protein levels in hSODG93A-derived astrocytes. Values shown are the means ± s.e.m. from three independent experiments.
**p < 0.01; ***p < 0.001
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hemichannel opening, ATP release, activation of P2X7R,
Ca2+ entry, early cell adhesion, and finally, cell polarization
and migration [21, 26, 53, 54]. In addition, hSOD1G93A-
derived astrocytes respond to Thy-1 without any require-
ment for additional cytokines. Of note, ectopically
expressed β3 Integrin increases the levels of other im-
portant players of the Thy-1-induced signaling path-
ways, including Syndecan-4 and the Connexin-43/
Pannexin-1 hemichannels, as well as markers of react-
ive astrocytes, such as iNOS and GFAP. Furthermore,
over-expression of β3 Integrin is sufficient to render as-
trocytes responsive to Thy-1. Therefore, we propose
that β3 Integrin plays a preponderant role in determin-
ing Thy-1-induced effects in astrocytes and possibly
also in controlling astrocyte reactivity.
After injury to the CNS, microglia generate a pro-
inflammatory environment by liberating TNF [11]. This
has been shown to enhance the expression of integrins
[55] and cell adhesion molecules, such as ICAM-1,
VCAM-1, and E-selectin [52, 56, 57]. In our studies,
TNF induced astrocyte reactivity, increasing the expres-
sion levels of reported markers of astrocytosis as well
as the Thy-1 receptors αVβ3 Integrin and Syndecan-4
[25, 28, 58]. Thy-1 receptor upregulation enables cells
to respond to the ligand and thereby initiate astrocyte
adhesion and migration. These findings suggest that a
pro-inflammatory environment is required for astro-
cytes to become responsive to neuronal signals such as
Thy-1. The low levels of β3 Integrin observed in pri-
mary astrocytes may explain the unresponsiveness of
these cells to Thy-1. In this context, it is of interest that
TNF also induces αVβ3 Integrin expression, along with
a αVβ3 Integrin-dependent cell migration, in endothelial
cells [44]; this indicates that increased αVβ3 Integrin ex-
pression is relevant to migration under pro-inflammatory
conditions in other cellular models.
In the present study, the application of TNF to pri-
mary astrocytes leads to an increased expression of αVβ3
Integrin, Syndecan-4, P2X7R, Connexin-43, and
Pannexin-1. All of these molecules have previously been
shown to be required for Thy-1-induced cell migration
[21]. Others have reported that Connexin-43 hemi-
channnels are activated by treating astrocytes with a
mixture of TNF and IL-1β. This leads to neuronal death,
an effect not observed in astrocytes lacking Connexin-43
[59]. Moreover, prenatal exposure to LPS, a well-known
pro-inflammatory agent, induces activation of astrocytes
with increased levels of Connexin-43 and Pannexin-1
[4]. Additionally, treating astrocytes with TNF for only
3 h induces expression of Connexin-43 hemichannels
[60]. These results suggest that primary astrocytes ex-
posed to a pro-inflammatory environment upregulate
surface receptors involved in the Thy-1-Integrin-induced
signaling pathways.
ATP release from hemichannels activated P2X7R and
thus increased intracellular calcium, only after TNF
treatment. ATP release and P2X7R activation has been
previously shown to be involved in Thy-1-induced astro-
cyte responses, first inducing cell adhesion [22] and sub-
sequently migration [21]. Of note, increased levels of
ATP have been associated with brain damage in humans.
Patients with radiation-induced brain injury show high
levels of extracellular ATP, IL-6, and TNF in cephalora-
chidian fluid [61]. In addition, exposure of primary
astroglial cultures to radiation increases extracellular
levels of ATP, IL-6, and TNF, unless P2X7R is inhibited
or silenced [61]. This suggests an important role for
ATP and P2X7R in the activation of glial cultures and
progression of brain injuries. Recently, increased expres-
sion of P2X7R and Connexin-43 has been linked to
astrogliosis in autoimmune encephalomyelitis, where the
increase of P2X7R coincided with the appearance of
astrocyte reactivity markers, such as GFAP and S100β.
The addition of P2X7R blockers led to a reduction in
astrogliosis markers [20], suggesting that the increase in
P2X7R is involved in astrocyte reactivity. In line with
this, published evidence indicates that P2X7R over-
expression leads to microglia activation [62, 63]. In the
present study, P2X7R protein levels increased after TNF
treatment, while the inhibition of P2X7R and the
apyrase-catalyzed reduction of extracellular ATP both
decreased Thy-1-induced astrocyte migration. However,
it remains to be determined whether P2X7R is a direct
or an indirect target of TNF.
The increase in [Ca2+]i induced by Thy-1 stimulus is
necessary for astrocyte migration. Ca2+ influx and Ca2+
release from intracellular stores via stimulation of IP3R
participate in Thy-1-induced astrocyte migration, since
P2X7R silencing as well as the addition of IP3R inhibi-
tors prevent the migration of astrocytes with a reactive
phenotype [21]. In addition, the calcium-chelator BAPTA-
AM blocks Thy-1-induced hemichannel opening and ATP
release, two key steps in the process of Thy-1-induced
DITNC1 astrocyte migration [21]. In agreement with our
observations, Fang and coworkers published that Orexin,
a neuropeptide that evokes responses similar to those trig-
gered by Thy-1 in astrocytes, induces migration in rat as-
trocytes in a Ca2+-dependent manner, which can be
blocked by either the addition of BAPTA-AM or an IP3R
blocker, such as 2-APB [64], supporting the notion that in-
creased [Ca2+]i is necessary for astrocyte migration.
In primary astrocytes, TNF treatment is required for
the Thy-1 response; however, TNF by itself neither in-
duces migration nor increases Ca2+ levels (Figs. 1c, d
and 2d), but rather promotes changes in protein expres-
sion to generate a migratory phenotype responsive to
Thy-1. Of note, αVβ3 Integrin, Syndecan-4, and P2X7
receptors trigger parallel and different signaling
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pathways [21]; thus, although elevated [Ca2+]i is required
for Thy-1-stimulated astrocyte migration, it is not ex-
pected to be sufficient alone to induce the migratory
phenotype, which results from more complex and inter-
connected signaling cascades.
Thy-1 elicits responses by engaging its receptors αVβ3
Integrin and Syndecan-4 [21, 22, 26]. Interestingly, β3
Integrin over-expression was sufficient to enable pri-
mary astrocytes to respond to Thy-1, thereby showing
an effect similar to that of TNF treatment. Others have
reported an increased cell migration, invasion and
tumorigenesis of cancer cells over-expressing β3 Integ-
rin following stimulation with osteopontin [65], an
extracellular matrix protein, which is upregulated and
secreted after TNF treatment, and which induces direc-
tional astrocyte migration in an αVβ3 Integrin-
dependent manner [18, 19]. This is in line with our
findings, since it indicates that increased levels of β3 In-
tegrin protein make cells more responsive to external
cues. However, over-expression of β3 Integrin alone
does not induce tumorigenesis in the absence of osteo-
pontin [65]. This is paralleled by our own observation
that in the absence of Thy-1, migration was not in-
creased in β3 Integrin over-expressing astrocytes, con-
firming that elevated levels of β3 Integrin render
astrocytes sensitive to the neuronal Thy-1, rather than
increasing cell autonomous migration. The intriguing
possibility that increased αVβ3 Integrin expression
might guide reactive astrocytes to regions rich in “dam-
age” signals, allowing them to interact with neuronal
Thy-1 in the damaged zone, awaits further studies.
Furthermore, β3 Integrin appears to control the ex-
pression of other proteins involved in the Thy-1 re-
sponse. It has been reported that αVβ3 Integrin acts
upstream of NF-κB in several cell types [66–68] and that
tyrosine 759 of β3 Integrin is required for NF-κB activa-
tion [68], suggesting that this pathway, or a similar one,
might be activated upon over-expression of β3 Integrin.
Like αVβ3 Integrin, the expression of the Thy-1 co-
receptor, Syndecan-4, is also increased in an NF-κB-
dependent manner when EAhy926 cells are treated with
TNF [69]. It is possible that NF-κB activation might in-
crease expression of the surface proteins reported in the
present study in response to TNF. In hepatocytes from
acute-on-chronic liver failure, increased levels of NF-κB
are associated with increased expression of Connexin-
43, but not Connexin-26 or Connexin-32 [70]. In iso-
lated aorta sections, Connexin-43 levels are increased
downstream of NF-κB and ERK1/2 activation [71]. Add-
itionally, IL-8 regulates αVβ3 Integrin expression in a
PI3K/Akt/NF-κB-dependent manner in MDA-MB-231
cancer cells [45]. Similarly, when glioblastoma multi-
forme cells are treated with the phorbol ester PMA, NF-
κB induces the expression of αVβ3 Integrin along with
fibronectin and vitronectin [72]. This suggests a possible
role for NF-κB in upregulating the expression of compo-
nents in the Thy-1 activated pathway. Consequently, β3
Integrin could be placed upstream or downstream of
NF-κB. Considering that β3 Integrin over-expression is
sufficient to increase the expression of reactive astrocyte
markers and to render astrocytes sensitive to Thy-1
stimulation in the absence of TNF, and since β3 Integrin
silencing precludes the effect of Thy-1 in TNF-treated
cells, we propose that β3 Integrin expression can control
astrocyte reactivity. Whether it does so by activating NF-
κB remains to be assessed.
To place our findings into a patho-physiological con-
text, astrocytes were analyzed from the hSOD1G93A ALS
mouse model. In this model, astrocytes are reported to
be reactive before the onset motor symptoms, and the
degree of reactivity correlates with the neurodegenera-
tive process [50]. Elevated expression levels of GFAP,
Vimentin, and CD44 in tissue sections from post-
mortem spinal cord in ALS patients also indicate astro-
cyte reactivity [36]. Here, Thy-1 is shown to induce ad-
hesion and migration of hSOD1G93A-derived astrocytes
without the need of prior TNF treatment. As might be
expected, Connexin-43 levels substantially increased in
these cells (Fig. 4c; see also [3]). For P2X7R, modest
levels of expression are associated with increased ALS
severity, as well as increased astrocyte and microglia re-
activity [1]. Consistent with this, we observed low levels
of P2X7R in hSOD1G93A astrocytes, suggesting that
these levels are sufficient for Thy-1-induced migration.
Therefore, astrocytes derived from hSOD1G93A mice are
reactive and responsive to Thy-1. Notably, unlike
P2X7R, Pannexin-1, Syndecan-4, and αVβ3 Integrin ex-
pression levels were increased. Such alterations have not
been associated with ALS to date, and further studies
are required to clarify the specific contribution of each
of these proteins.
Conclusions
We show for the first time that primary astrocytes must
be primed by exposure to a pro-inflammatory environ-
ment before they can change their shape, adhesion, and
migratory properties in response to neuronal Thy-1. β3 In-
tegrin was identified as a fundamental mediator of Thy-1-
induced migration, not only as a receptor, but also as a
regulator of the signaling pathway downstream of the
Thy-1 receptors. In addition, we propose β3 Integrin as a
key target to control astrocyte reactivity. Finally, a novel
association of Pannexin-1, Syndecan-4, and β3 Integrin
with ALS is here uncovered. Therefore, our results sup-
port Thy-1 and β3 Integrin/Syndecan-4 as potential tar-
gets for the clinical management of neurodegenerative
diseases involving inflammatory processes.
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Additional file 1: Figure S1. A) Representative western blot of astrocyte
reactivity markers GFAP and iNOS from wild-type rat astrocytes treated or
not with TNF. B) Representative images of GFAP immunofluorescence from
rat primary astrocytes treated or not with TNF. Magnification bar = 50 μm.
C) Quantification of rat primary astrocytes harboring FAs in control cells or
cells treated with IL-1β, IL-6, or TNF, and stimulated or not with Thy-1-Fc or
FBS. Values shown are the means ± s.e.m. from three independent
experiments. ***p < 0.001. (PDF 2294 kb)
Additional file 2: Figure S2. Representative western blot of β3 Integrin
from rat astrocytes treated with Il-6, IL+db cAMP, IL-1β, IL-1β+db cAMP,
or IFN-γ. (PDF 77 kb)
Additional file 3: Figure S3. β3 Integrin over expression permits Thy-1-
induced signaling. A) Quantification of intracellular calcium levels in rat
primary astrocytes transfected with pEGFP-β3 Integrin or pEGFP and
stimulated with Thy-1-Fc. Trail-R2-Fc was used as a negative control. Cells
were starved for 30 min. The arrow indicates the addition of Thy-1. B)
Extracellular ATP measurement of primary astrocytes transfected with
pEGFP-β3 Integrin or pEGFP, and treated with Trail-R2-Fc or Thy-1-Fc for
10 min. Cells were previously starved for 30 min. Values shown in the
graph are the mean ± s.e.m. from three independent experiments.
*p < 0.05. (PDF 174 kb)
Additional file 4: Figure S4. Representative western blot of the markers
of astrocyte reactivity GFAP and iNOS from non-transgenic and hSOD1G93A-
derived astrocytes. β-actin is a loading control. (PDF 166 kb)
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